Surgical Site Infection Market To Display Fastest Growth In Asia-pacific

By Author: Pramod Kumar
Total Articles: 97
Comment this article

The key factors helping in this growth include a surge in the incidence of SSIs, increase in the number of surgical procedures, rise in the geriatric population, and development of technologically improved products. Additionally, favorable government regulations will propel the market growth during the forecast period.

The major reason behind the growth of the market is the increasing volume of surgeries. Such medical procedures are done for therapeutic as well as diagnostic purposes, which is why operating rooms (OR) remain ever-busy. Every surgery, however minimally invasive, requires cutting into the flesh, which leads to wounds. Despite taking place in the cleanest of OR, every surgery carries a risk of infection at the operated-upon site. Therefore, with the increasing incidence of chronic diseases pushing up the surgery volume, the demand for SSI management products is rising too.

The product segment of the surgical site infection market is categorized into antiseptics and disinfectants, antibiotic prophylaxis products, surgical drapes, wound care dressings, patient warming products, wound irrigation products, ...
... surgical staff clothing, clippers, wound care supplementary products, and others. Of these, antibiotic prophylaxis products dominated the market in 2017, as they are the most common preventive measures adopted by healthcare facilities to prevent contamination and infection during treatment. Additionally, the antiseptics and disinfectants category is expected to display the fastest growth during the forecast period.

Considering the regional scenario, North America generated the highest revenue in the surgical site infection market in 2017 due to the growing awareness about SSIs, advanced healthcare sector, and presence of leading market players. These factors, coupled with the increasing number of surgeries and surging elderly population, are propelling the market growth. Moreover, during the forecast period, the Asia-Pacific (APAC) region is projected to showcase the fastest growth, driven by the rising population of the elderly, increasing incidence of SSIs, improving healthcare system, and adoption of improved products.

To gain the maximum benefit in the surgical site infection market, players are taking strategic measures including mergers and acquisitions. For example, Molnlycke Health Care AB partnered with Tissue Analytics in January 2018 to together develop and commercialize advanced digital solutions for wound care professionals. Other key players in the industry taking such measures include HARTMANN GROUP, Covalon Technologies Ltd., STERIS plc, Surgical Site Infection Prevention LLC, B. Braun Melsungen AG, Stryker Corporation, 3M Company, Prescient Surgical Inc., and Becton, Dickinson and Company.

Thus, the increasing awareness about SSIs and number of surgeries will propel the market growth during the forecast period.

Report Description: https://www.psmarketresearch.com/market-analysis/surgical-site-infection-market

Pramod has around 7 years of experience in market research and consulting services for healthcare industry. He holds varied experience in market sizing and forecasting with varied models, competition landscape, consumer behavior analysis, opportunity analysis, product/company benchmarking, data mining and others. He has successfully delivered multiple projects on go-to-market strategies, pricing strategy, price point analysis, Business Expansion, market entry and exit, share analysis and others. Prior to joining P&S Intelligence, he worked with different research companies, including Transparency Market Research and MarketsandMarkets Pvt Ltd. Some of the projects delivered by him include Scar Treatment Market, Skin Replacement and Substitutes Market, and Energy-Based Aesthetic Devices Market.